| Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro MM Pinheiro, CL Stoppa, CJ Valduga, CE Okuyama, R Gorjao, ... European Journal of Pharmaceutical Sciences 100, 17-24, 2017 | 73 | 2017 |
| Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i) MM Pinheiro, A Fabbri, M Infante Immunotherapy 13 (9), 753-765, 2021 | 45 | 2021 |
| Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3 MM Pinheiro, FMM Pinheiro, MA Torres Endocrinology, Diabetes & Metabolism Case Reports 2016 (1), 2016 | 31 | 2016 |
| Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes MM Pinheiro, FMM Pinheiro, SN Diniz, A Fabbri, M Infante International Immunopharmacology 95, 107518, 2021 | 22 | 2021 |
| Dipeptidyl peptidase-4 inhibitors (DPP-4i) combined with vitamin D3: An exploration to treat new-onset type 1 diabetes mellitus and latent autoimmune diabetes in adults in the … MM Pinheiro, FMM Pinheiro, ML Trabachin International Immunopharmacology 57, 11-17, 2018 | 18 | 2018 |
| Editorial–COVID-19 pandemic: is it time to learn about DPP-4/CD26? MM Pinheiro¹, JM Pinheiro, FMM Pinheiro Diabetes Obes Metab 17, 379-385, 2015 | 10 | 2015 |
| Subclinical apoplexy in pituitary tumors MM Pinheiro, A Cukiert, LR Salgado, M Nery, J Goldman, F Pimentel, ... Arquivos de Neuro-psiquiatria 57 (1), 74-77, 1999 | 9 | 1999 |
| Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study MM Pinheiro, FMM Pinheiro, MM Arruda, GM Beato, GACL Verde, ... Archives of Endocrinology and Metabolism 67, e000652, 2023 | 8 | 2023 |
| Moura Maia Pinheiro F, Pires Amaral Resende LL, Nogueira Diniz S, Fabbri A, Infante M. Improvement of pure sensory mononeuritis multiplex and IgG1 deficiency with sitagliptin … M Maia Pinheiro Eur. Rev. Med. Pharmacol. Sci 24 (15), 8151-8159, 2020 | 8 | 2020 |
| Improvement of pure sensory mononeuritis multiplex and IgG1 deficiency with sitagliptin plus Vitamin D3 MI M. Maia Pinheiro, F. Moura Maia Pinheiro, L.L. Pires Amaral Resende, S ... Eur Rev Med Pharmacol Sci 24 (15), 8151-8159, 2020 | 8 | 2020 |
| 36-month follow-up of a pure sensory mononeuritis multiplex and IgG1 deficiency improved after treatment with sitagliptin and Vitamin D3 M Maia Pinheiro, FM Maia Pinheiro, S Diniz, A Fabbri, M Infante European Review for Medical and Pharmacological Sciences 25 (4), 1768-1769, 2021 | 7 | 2021 |
| Paralisia periódica hipocalêmica como primeiro sintoma de hipertireoidismo: relato de caso AK Grzesiuk, MM Pinheiro, N Figueiredo Neto, EN Rosa Arquivos de Neuro-Psiquiatria 60, 490-492, 2002 | 5* | 2002 |
| Identical twins discordant for Cushing's disease: case report M PINHEIRO, B LIBERMAN, LR SALGADO, J GOLDMAN, M NERY, ... Arquivos de Neuro-Psiquiatria 57, 686-688, 1999 | 5 | 1999 |
| Prolonged Clinical Remission of Type 1 Diabetes Mellitus Treated with Sitagliptin and Vitamin D3 Could Be Related to Changes in CD8 (+) Lymphocytes Count Expressing CD26 (+) MM Pinheiro Sr, CB Pizarro, FMM Pinheiro DIABETES 66, LB68-LB68, 2017 | 4 | 2017 |
| Asymptomatic apoplexy in pituitary tumors MM PINHEIRO, A CUKIERT, LR SALGADO, M NERY, J GOLDMAN, ... Arquivos de Neuro-Psiquiatria 57, 74-77, 1999 | 3 | 1999 |
| Comment on Russell et al. Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked, controlled trial. Diabetes Care 2023; 46 … MM Pinheiro, FMM Pinheiro Diabetes Care 46 (11), e209-e209, 2023 | 1 | 2023 |
| Prolonging the honeymoon phase in T1DM with sitagliptin plus vitamin D3 M Pinheiro, F Pinheiro DIABETES TECHNOLOGY & THERAPEUTICS 22, A26-A26, 2020 | 1 | 2020 |
| PRE1BRAZIL Protocol: A Randomized Controlled Trial to Evaluate the Effectiveness and Safety of the DPP-4 Inhibitor Alogliptin in Delaying the Progression of Stage 2 Type 1 Diabetes JG Penaforte-Saboia, CEB Couri, NV Albuquerque, LLP Linard, ... Diabetes, Metabolic Syndrome and Obesity, 857-864, 2024 | | 2024 |
| Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways MM Pinheiro, FMM Pinheiro, ML Garo, D Pastore, F Pacifici, C Ricordi, ... Metabolism and Target Organ Damage 4 (3), N/A-N/A, 2024 | | 2024 |
| Comment on Narsale et al. Th2 cell clonal expansion at diagnosis in human type 1 diabetes. Clin Immunol. 2023 Oct 29. MM Pinheiro, FMM Pinheiro, SN Diniz Clinical Immunology (Orlando, Fla.) 258, 109873-109873, 2023 | | 2023 |
Susana Nogueira DinizUniversidade Anhanguera de São Paulo在 anhanguera.com 的电子邮件经过验证
